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INTRODUCTION
It is well known that dopamine (DA) is necessary for motor function, motivation, working memory, and reward (Girault and Greengard, 2004; Phillips et al., 2008) . DA signaling dysfunction has been implicated in various neuropsychological diseases, including Parkinson's disease, drug addiction, compulsive behavior, attention-deficit/hyperactivity disorder, autism spectrum disorders, and schizophrenia (Carlsson, 2001; Hyman et al., 2006; Iversen and Iversen, 2007; Koob and Volkow, 2010; Swanson et al., 2007) . The principal target of DA is medium spiny neurons (MSNs), which are a special type of GABAergic inhibitory cell that comprise 95% of the neurons within the striatum, including the nucleus accumbens (NAc). There is a distinct class of spatially intermixed MSNs that express DA type 1 or 2 receptors (D1R-MSNs or D2R-MSNs, respectively). The D1R is coupled to adenylate cyclase through G olf and activates protein kinase A (PKA), whereas the D2R inhibits adenylate cyclase through G i (Hervé et al., 1993; Stoof and Kebabian, 1984) . DA acts to increase the excitability of D1R-MSNs and their response to glutamatergic synaptic input from the cerebral cortex and thalamus (Surmeier et al., 2007) . Conversely, DA appears to reduce the excitability of D2R-MSNs. When DA levels are relatively low during rest, D1R-MSNs appear to be less excitable than D2R-MSNs (Gertler et al., 2008) . Thus, the D2R-MSN pathway may predominate under basal conditions. When a substantial increase in DA is induced by reward-related DA release or cocaine administration, the D1R-MSN pathway becomes more dominant than the D2R-MSN pathway. In vivo Ca 2+ imaging has demonstrated that acute cocaine induces fast activation of D1R-MSNs and progressive deactivation of D2R-MSNs (Luo et al., 2011) . The D1R-mediated neuronal pathway has been implicated in reward-related behaviors such as appetitive reward learning and adaptive responses to cocaine (Hikida et al., 2010) .
Based on pharmacological observations, PKA is thought to regulate not only the excitability of MSNs but also the synaptic plasticity that controls reward-related behaviors (Hopf et al., 2003; Self et al., 1998) . However, whether and how PKA regulates the excitability of MSNs and reward-related behaviors remain largely unknown. A systematic survey of cAMP-activated phosphoproteins in various brain regions was first carried out by Paul Greengard and his colleagues more than 30 years ago (Walaas et al., 1983b (Walaas et al., , 1983c . Since their achievement, major effort has been made to identify the target substrates of PKA to understand the modes of action of DA, and a few of its substrates, including DARPP-32, GluR1, and NR1, have been reported. DARPP-32 appears to control synaptic plasticity through the inhibition of protein phosphatase-1 (Nishi et al., 2011; Yagishita et al., 2014) . GluR1 and NR1 phosphorylation appears to enhance surface expression of both AMPA and NMDA receptors, which may be involved in synaptic plasticity (Snyder et al., 2000; Hallett et al., 2006) . However, these substrates do not explain how D1Rs and PKA regulate neuronal excitability or how these processes control behavior.
To identify PKA substrates that regulate the excitability changes that are associated with rewarding experiences and to more broadly examine PKA substrates, we developed a phosphoproteomic analysis method that uses affinity beads coated with 14-3-3 proteins to enrich phosphorylated proteins. Using this approach, we comprehensively identified PKA substrates downstream of D1Rs in the striatum to elucidate PKA-mediated signaling pathways. We found more than 100 candidate substrates of PKA, including Rap1 GEF (Rasgrp2). We also found that DA stimulated Rasgrp2 phosphorylation via PKA, thereby activating Rap1, and that Rap1 regulated neuronal excitability and cocaine-induced behavioral reward responses through MAPK (ERK).
RESULTS

Phosphoproteomic Analysis of D1R Signaling
To explore novel phosphorylation events downstream of the D1R, we utilized acute slices of the mouse striatum. Because D1R agonists have been shown to activate PKA to phosphorylate DARPP-32 at Thr 34 (T34), GluR1 at Ser 845 (S845), and NR1 at Ser 897 (S897) (Dudman et al., 2003; Snyder et al., 2000; Walaas et al., 1983a) , we first confirmed the phosphorylation of these proteins in striatal slices after stimulation with SKF81297 (a D1R agonist) and forskolin, which specifically produces cyclic AMP and subsequent activation of PKA. The addition of SKF81297 and forskolin induced the phosphorylation of not only DARPP-32 at T34 (p < 0.01), GluR1 at S845 (p < 0.01), and NR1 at S897 (p < 0.05) but also MAPK1/3 (ERK1/2) at Thr 202/Tyr 204 (T202/Y204, p < 0.01; Figure 1A ). In the striatum, the phosphorylation and activation of MAPK1/3 downstream of the D1R appear to be mediated by PKA (Ambrosini et al., 2000; Shiflett and Balleine, 2011) .
We then developed a phosphoprotein screening method to more comprehensively identify the PKA substrates downstream of the D1R, as depicted in Figure 1B . Striatal slices were treated with forskolin to induce PKA-mediated phosphorylation. Extracts from these striatal slices were then applied to affinity beads coated with 14-3-3 protein to enrich for Thr-or Ser-phosphorylated proteins. The bound proteins were digested using trypsin and subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify the phosphorylated proteins and their phosphorylation sites. Treatment with forskolin stimulated the phosphorylation of more than 200 proteins. The phosphorylation sites that exhibited stimulus-induced activation that was at least 5-fold greater than the control level are summarized in Table 1 . Detailed information about the phosphorylation sites is summarized in Table S1 , available online (the information will be available in the Kinase-Associated Neural PhosphoSignaling Database; https://srpbsg01.unit.oist.jp/index.php? ml_lang=en). Motif analysis of the phosphopeptides that were identified using this method revealed that approximately 60% of the phosphorylation sites contained basic residues at the À3 and À2 positions, suggesting that PKA or a related kinase was responsible for these phosphorylation events. Approximately 20% of these sites contained Pro at the +1 position, suggesting that they are phosphorylation sites for MAPK1/3 or other Pro-oriented kinases. We also found that the addition of SKF81297 increased the phosphorylation of more than 100 proteins (Table 1) . In total, 47 of these phosphoproteins were also identified following forskolin stimulation; again, these sites were predominantly categorized as putative PKA and MAPK1/3 target sites ( Figure S1 ; Table 1 ). Of note, most of these proteins and phosphorylation sites have not yet been reported as part of the DA-D1R signaling pathway.
Because we were interested in the direct target substrates of PKA located downstream of the D1R, we identified the putative PKA substrates that were phosphorylated upon stimulation with SKF81297 and entered these substrates into a curated pathway database, Reactome (http://www.reactome.org), to identify the signaling pathways related to the obtained PKA substrates. We identified Rap1 signaling, potassium channels, and hyperpolarization-activated cyclic nucleotide-gated (HCN) channels as major PKA-related pathways (Table S2) .
Among the putative PKA substrates in the Rap1 pathway, Rasgrp2 (CalDAG-GEF1) and Rap1gap are positive and negative regulators of Rap1, respectively (Bos et al., 2007; Clyde-Smith et al., 2000; Kedra et al., 1997; Rubinfeld et al., 1991) . Rap1 is a small GTPase that has been implicated in synaptic plasticity in hippocampal neurons and in memory formation (Morozov et al., 2003; Pan et al., 2008; Stornetta and Zhu, 2011) . Thus, we speculated that the Rap1 pathway is involved in the regulation of neuronal functions via D1R signaling, and we subsequently focused on the Rap1 pathway, especially Rasgrp2, because guanine nucleotide exchange factors (GEFs) are primarily responsible for the activation of small GTPases.
PKA Phosphorylates Rasgrp2 at Ser 116, Ser 117, Ser 554, and Ser 586 Both In Vitro and in Striatal Slices SKF81297-induced phosphorylation of Rasgrp2 at Ser 116 (S116), Ser 117 (S117), and Ser 554 (S554) was observed in mouse striatal slices (Table 1) . To confirm whether PKA directly phosphorylates these sites, GST-Rasgrp2 was subjected to in vitro phosphorylation analysis. Because Ser 586 (S586) is a putative PKA phosphorylation site in addition to S116, S117, and S554, a tetra-substituted Ala mutant (Rasgrp2-116A/ 117A/554A/586A) was examined. GST-Rasgrp2 was efficiently A B Figure 1 . Screening for Phosphoproteins in Striatal Slices (A) SKF81279 and forskolin stimulated the phosphorylation of DARPP-32, GluR1, NR1, and MAPK1/3. Striatal slices were treated with either forskolin (1 mM) or SKF81297 (1 mM) for 10 min. The left panels show immunoblots and the corresponding total proteins. Quantification of the immunoblot assay is shown in the right panels. The data are presented as scatterplots in which each point represents an experimental point. The horizontal bars show the mean ± SEM. *p < 0.05, **p < 0.01. (B) Scheme and chart for the phosphoproteomic analysis used to identify PKA substrates downstream of the D1R. Striatal slices were treated with SKF81297 or forskolin to induce PKA-mediated phosphorylation. Extracts of these striatal slices were then applied to affinity beads coated with 14-3-3 to enrich phosphorylated proteins. The bound proteins were digested using trypsin and subjected to LC-MS/MS to identify the phosphorylated proteins and their phosphorylation sites. 
phosphorylated by PKA in vitro, and the tetra-substituted mutant exhibited an approximately 50% reduction in the phosphorylation level ( Figure 2A ). We further produced phosphorylation state-specific antibodies for S116/S117 (pS116/pS117), S554 (pS554), and S586 (pS586). These antibodies specifically recognized PKA-mediated phosphorylated Rasgrp2 but did not crossreact with nonphosphorylated Rasgrp2 or with the site-specific Ser-to-Ala Rasgrp2 mutant ( Figure 2B , Figure S2 ). These results indicate that PKA directly phosphorylates Rasgrp2 at S116, S117, S554, and S586 in vitro. We next examined whether SKF81297 and forskolin induced the phosphorylation of Rasgrp2 in acute striatal slices using these phospho-specific antibodies. Treatment of the slices with SKF81297 and forskolin stimulated the phosphorylation of Rasgrp2 at S116, S117, S554, and S586 (p < 0.01; Figure 2C ). To investigate whether the phosphorylation of Rasgrp2 is mediated by PKA in the brain, striatal slices were pretreated with the PKA inhibitor Rp-cAMPS before SKF81297 or forskolin treatment as previously described (Biever et al., 2015) . SKF81297-and forskolin-stimulated phosphorylation of Rasgrp2 was blocked by the PKA inhibitor Rp-cAMPS (p < 0.05; Figure 2C ). These findings suggest that DA stimulates the phosphorylation of Rasgrp2 by acting through D1R-mediated activation of PKA and, together with the phosphoprotein screening data, reveal a novel PKA-Rasgrp2 signaling pathway.
We also performed a pull-down assay using affinity beads coated with 14-3-3 and found that treating the slices with SKF81297 and forskolin increased the amount of Rasgrp2 bound to 14-3-3 (p < 0.01; Figure 2D ). These results suggest that PKA phosphorylates Rasgrp2 and induces its association with 14-3-3. Because 14-3-3 has been shown to bind to phosphorylated proteins and to alter their localization, activity, and stability 
Striatal slices were treated with forskolin to induce PKA-mediated phosphorylation. The extracts of these striatal slices were then applied to affinity beads coated with 14-3-3 protein to enrich the phosphorylated proteins. The bound proteins were digested using trypsin and subjected to LC-MS/ MS to identify the phosphorylated proteins and their phosphorylation sites. Treatment with forskolin stimulated the phosphorylation of more than 200 proteins. The reproducible phosphorylation sites, which were stimulated by more than 5-fold compared to the control at least twice in more than three independent experiments, are summarized. See also Figure S1 and Tables S1 and S2 . (B) The specificity of the antibodies against phosphorylated Rasgrp2 mediated by PKA. A total of 500 fmol of GST-Rasgrp2-1-374 aa (for the pS116/pS117 antibody) or GST-Rasgrp2-495-609 aa (for the pS554 and pS586 antibodies) containing the indicated amount of phosphorylated or nonphosphorylated protein was subjected to SDS-PAGE followed by immunoblot analysis using phospho-specific antibodies.
(C) Forskolin and SKF81279 stimulated the phosphorylation of Rasgrp2 in striatal slices. Striatal slices were treated with either forskolin (1 mM) or SKF81297 (1 mM) for 10 min after they were pretreated with Rp-cAMPS (1 mM) 60 min before. The top panels show representative immunoblots. Quantification of the immunoblotting assay is shown in the bottom panels.
(legend continued on next page) (Morrison, 2009; Obsil and Obsilova, 2011) , whether the phosphorylation of Rasgrp2 affects its guanine nucleotide exchange activity was an intriguing question.
PKA Stimulates Rap1 Activity via the Phosphorylation of Rasgrp2 Downstream of D1Rs
To measure guanine nucleotide exchange activity on Rap1, we utilized beads coated with nucleotide-free Rap1 (Rap1 G15A) and performed an affinity precipitation assay to specifically pull down Rasgrp2 that was activated in intact cells, as described previously (Chen et al., 1994; Cherfils and Chardin, 1999) . When COS-7 cells were transfected with EGFP-Rasgrp2, a small amount of EGFP-Rasgrp2 precipitated with Rap1 G15A (Figure 3A) . The coexpression of the catalytic unit of PKA (myc-PKA) dramatically increased the amount of EGFP-Rasgrp2 that precipitated with Rap1 G15A and stimulated the phosphorylation of Rasgrp2 at S116, S117, S554, and S586 (p < 0.01; Figure 3A) . The coexpression of myc-PKA did not affect the amount (D) Forskolin and SKF81297 stimulated the association of Rasgrp2 with 14-3-3 in striatal slices. Striatal slices were treated with either forskolin (10 mM) or SKF81297 (1 mM) for 10 min. The left panels show an immunoblot for Rasgrp2 that was pulled down by GST-14-3-3 and for total Rasgrp2. Quantification of the immunoblotting assay is shown in the right panels. The data in (C) and (D) are presented as scatterplots in which each point represents an experimental point. The horizontal bars show the mean ± SEM. *p < 0.05, **p < 0.01. See also Figure S2 . of unphosphorylatable mutant Rasgrp2 (Rasgrp2-116A/117A/554A/586A) that precipitated with Rap1 G15A or the phosphorylation of this mutant ( Figure 3A) . When COS-7 cells were transfected with phospho-mimic mutant Rasgrp2 (Rasgrp2-116D/117D/554D/586D and Rasgrp2-116E/117E/554E/586E), a large amount of Rasgrp2 precipitated with Rap1 G15A compared to that precipitated in EGFP-Rasgrp2-transfected control cells (p < 0.05; Figure 3B ). These results indicate that PKA phosphorylates Rasgrp2 and activates its guanine nucleotide exchange activity on Rap1 in COS-7 cells.
To examine whether SKF81297 and forskolin affect the levels of the GTP-bound form of Rap1 in striatal slices, we utilized beads coated with RalGDS, an effector of Rap1, and performed an affinity precipitation assay to specifically pull down the GTP-bound form of Rap1 (Rap1-GTP). Treatment of the slices with SKF81297 and forskolin increased the levels of Rap1-GTP (p < 0.05; Figure 3C ). Taken together, these results suggest that D1R agonists activate Rap1 via PKA-mediated phosphorylation of Rasgrp2.
Cocaine Stimulates PKA-Rasgrp2 Signaling, Thereby Activating Rap1 in the NAc of Mice Rasgrp2 has been shown to be predominantly expressed in the MSNs of the striatum (Kawasaki et al., 1998; Toki et al., 2001; Crittenden et al., 2009 Crittenden et al., , 2010 Crittenden and Graybiel, 2011) . Consistent with previous reports, immunohistochemistry using specific Rasgrp2 antibodies revealed that Rasgrp2 was highly expressed in the NAc and striatum compared with other brain regions, including the cerebral cortex ( Figure 4A ). Next, we examined the phosphorylation of Rasgrp2 in the NAc by immunoblotting after cocaine injection. Treatment with a single dose of cocaine significantly and dose-dependently increased the phosphorylation level of Rasgrp2 at S116/S117, S554, and S586 in the NAc 15 min after treatment (p < 0.05; Figure 4B ). To investigate if cocaine stimulates the phosphorylation of Rasgrp2 in D1R-MSNs, we performed immunohistochemical analysis in Drd1-mVenus transgenic mice, in which D1R-MSNs express a variant of yellow fluorescent protein (mVenus). Cocaine-induced phosphorylation of Rasgrp2 was detected in D1R-MSNs in the NAc of Drd1-mVenus transgenic mice ( Figure 4C ). Furthermore, cocaine administration significantly increased the level of activated Rap1 in the NAc 15 min after cocaine injection, as assessed by Rap1-GTP levels, which were measured via a GST-RalGDS pull-down assay (p < 0.05; Figure 4D ). These results demonstrate that cocaine stimulates PKA-Rasgrp2 signaling, thereby activating Rap1 in the NAc of mice. PKA in D1R-MSNs regulates neuronal excitability and rewardrelated behaviors. We next established a system in which wildtype PKA (wtPKA) or constitutively active mutant PKA (caPKA, a form of the PKA catalytic subunit that is not regulated by cAMP [H87Q and W196R]; Orellana and McKnight, 1992) was expressed in the NAc under the control of the D1R promoter using adeno-associated virus (AAV)-mediated conditional transgenic techniques ( Figure 5A , Figure S3A ). We injected AAV-FlexwtPKA or AAV-Flex-caPKA mutant into the NAc of Drd1a-Cre transgenic mice and compared the results to those obtained following injection of the AAV-Flex-EGFP control vector. Immunoblot analysis revealed that the expression of caPKA increased the phosphorylation level of Rasgrp2 at S116/117, S554, and S586 but did not alter the level of total Rasgrp2 compared to the expression of EGFP (p < 0.05; Figure 5B ), demonstrating that PKA activity can be manipulated in accumbal D1R-MSNs and that the activation of PKA promotes Rasgrp2 phosphorylation in vivo. Next, we performed whole-cell current-clamp recordings of mutant PKA-transfected D1R-MSNs in the NAc to examine their intrinsic membrane excitability, as measured by the number of action potentials generated by a positive current injection. Interestingly, the caPKA-transfected cells showed a significantly higher number of spikes than the EGFP-transfected control cells (p < 0.05; Figure 5C ). No marked differences in the currentvoltage (I-V) curves were observed between the three groups of mice ( Figure S4 ). We also confirmed that treatment of the accumbal slices with forskolin increased the number of spikes (data not shown), as described previously (Hopf et al., 2003) . Moreover, to assess the behaviorally relevant consequences of PKA activity, we used a cocaine-induced conditioned placepreference model. At a conditioning dose of 10 mg/kg, cocaine induced place preference to the drug-paired side in EGFPtransfected mice (p < 0.01), whereas saline treatment had no effect on place preference ( Figure 5D ). As expected, the rewarding effects of cocaine were markedly potentiated in mice that expressed caPKA in D1R-MSNs of the NAc (p < 0.05; Figure 5D ). These results indicate that PKA activation increases the phosphorylation of Rasgrp2 and the excitability of D1R-MSNs in the NAc to enhance the sensitivity of mice to the cocaine reward.
PKA-Mediated Rap1 Activation in Accumbal D1R-MSNs Controls Neuronal Excitability and Cocaine-Induced Place Preference
To further study the role of Rap1 in MSNs, wild-type Rap1 (wtRap1) or constitutively active mutant Rap1 (caRap1, the fast-cycling variant of Rap1a [F28L]; Reinstein et al., 1991) was expressed in the D1R-MSNs of the NAc. A GST-RalGDS pulldown assay revealed an increase in the Rap1-GTP level in the NAc of both the AAV-Flex-wtRap1-and AAV-Flex-caRap1-injected Drd1a-Cre transgenic mice, although the level of activated Rap1 in the caRap1-transfected mice was higher than that in the wtRap1-transfected mice (p < 0.05; Figure 6A ). Consistent with our observation for mutant PKA, the number of spikes in caRap1-transfected D1R-MSNs was significantly higher than that in EGFP-transfected control cells (p < 0.05; Figure 6B) , with no differences in the I-V curves ( Figure S4 ). The expression of caRap1 in D1R-MSNs also significantly potentiated cocaine-induced place preference (p < 0.01), whereas the expression of this Rap1 mutant had no effect on conditioned place preference in saline-treated mice ( Figure 6C ). These results indicate that the activation of Rap1 increases neuronal excitability and the rewarding effect of cocaine. Because Rap1 has been implicated in the control of dendritic spine structural plasticity in cultured cortical and hippocampal pyramidal neurons (Xie et al., 2005; Zhu et al., 2002) , we investigated whether the activation of Rap1 might be involved in the spine morphology of accumbal D1R-MSNs. We coinjected AAV-Flex-wtRap1 or AAV-Flex-caRap1 mutant together with AAV-substance P (SP)::Cre into the NAc of C57BL/6 mice and compared the results to those obtained following injection of the AAV-SP::Cre and AAV-Flex-EGFP control vectors. Dendritic spine analysis revealed that the expression of either wtRap1 or caRap1 in D1R-MSNs had no effect on the number of spines or their morphology ( Figure 6D ), suggesting that the contribution of Rap1 signaling to the morphology of the spines of D1R-MSNs is minimal.
We examined whether endogenous Rap1 in D1R-MSNs of the NAc is required for neuronal firing and cocaine reward. To this end, homozygous loxP-flanked (floxed) Rap1 mice (Rap1 flx/flx ) were administered AAV-SP::Cre into the NAc (Figure 7A , Figure S3B ). The expression of Cre in D1R-MSNs significantly decreased Rap1 protein expression in the NAc, as revealed by immunoblotting (p < 0.01; Figure 7A ). Localized knockout of Rap1 notably decreased evoked action-potential firing and diminished cocaine-induced place preference compared with the control treatment (p < 0.05 and p < 0.05; Figures 7B and 7C , respectively). It should be noted that the deficit in cocaine-induced place preference in Rap1 knockout mice was restored by cotransfection with caRap1 (p < 0.05), but not caPKA ( Figure 7C ). Taken together, these results indicate that Rap1 is required for neuronal excitability and cocaine reward ( Figure 7D ).
Rap1 Mediates the Activation of MAPK1/3 by PKA Downstream of D1Rs
Rap1 is known to activate B-raf, resulting in the activation of MAP2K (MEK), followed by MAPK1/3 activation (Sweatt, 2001) . Consistently, we found that the activation of Rap1 that was induced by treatment with SKF81297 and forskolin was accompanied by the activation of MAPK1/3 ( Figure 1 and Table 1 Figures S5A-S5C ).
The number of spikes in caMAP2K1-transfected D1R-MSNs was significantly higher than that in EGFP-transfected control cells, whereas the number of spikes was reduced in dnMAP2K1-transfected D1R-MSNs (p < 0.05; Figure S5D ). Compared to EGFP control transfection, the expression of caMAP2K1 in D1R-MSNs also significantly potentiated cocaineinduced place preference (p < 0.05), whereas the opposite effect was observed in the case of dnMAP2K1 expression (p < 0.05; Figure S5E) . When dnMAP2K1 was cotransfected with caPKA or caRap1 in D1R-MSNs of the NAc, dnMAP2K1 diminished the increased sensitivity to cocaine reward induced by caPKA or caRap1 ( Figures S5F and S5G ). The deficit in cocaine-induced place preference in Rap1 knockout mice was restored by cotransfection with caMAP2K1 (p < 0.05; Figure S5H ). These results indicate that Rap1 mediates the activation of MAPK1/3 by PKA downstream of D1Rs ( Figure 7D ).
DISCUSSION
Rasgrp1-4 are members of a family of genes that is characterized by the presence of a Ras superfamily GEF domain (Bos et al., 2007) . In the brain, Rasgrp1 (CalDAG-GEFII) and Rasgrp2 are enriched in striatal neurons, whereas Rasgrp3 is enriched in oligodendrocytes of the cerebellum and cerebral cortex (Toki et al., 2001; Yamashita et al., 2000) . Although Rasgrp1 and Rasgrp2 have been implicated in basal ganglia disorders, including L-DOPA-induced dyskinesias and Huntington's disease (Crittenden et al., 2009 (Crittenden et al., , 2010 Crittenden and Graybiel, 2011) , it remains unclear how DA controls the GEF activity of Rasgrp2. The present study provides the first demonstration of a mechanistic link with the D1R. We found that PKA phosphorylates Rasgrp2 at S116, S117, S554, and S586, promoting its binding to 14-3-3 and activating its guanine nucleotide exchange activity on Rap1. Multiple-alignment analysis of mouse Rasgrp1-4 revealed that the PKA phosphorylation sites identified in Rasgrp2 were not conserved in other Rasgrp proteins ( Figure S6 ), suggesting that the regulatory mechanism of Rasgrp2 by PKA is not conserved among Rasgrp family proteins.
We also found that treatment of striatal slices with a D1R agonist and peritoneal injection of cocaine induced Rasgrp2 phosphorylation and Rap1 activation. These results suggest that Rap1 is activated via PKA-mediated phosphorylation of Rasgrp2 downstream of D1Rs. Because most GEFs that act on the Ras family of GTPases are maintained in an inactive form, it is conceivable that the binding of Rasgrp2 to 14-3-3 changes the conformation of Rasgrp2 from an inactive state to an active state. We found that Rap1 is involved in the neuronal excitability of D1R-MSNs. Rap1 has various effectors, including AF-6/afadin, B-raf, RalGDS, and Riam (Caron, 2003; Stork, 2003) . Rap1 and AF-6 have been implicated in the control of spine-neck (legend continued on next page) elongation in cultured cortical and hippocampal pyramidal neurons (Woolfrey et al., 2009; Xie et al., 2005; Zhu et al., 2002) . However, the contribution of Rap1 signaling to the spine morphology of D1R-MSNs appears to be minimal because the expression of caRap1 in D1R-MSNs had no effect on their spine morphology. Rap1 is known to activate B-raf, which results in the activation of MAP2K1/2, followed by MAPK1/3 activation (Sweatt, 2001) . We found that the activation of Rap1 that was induced by treatment with SKF81297 and forskolin was accompanied by the activation of MAPK1/3. Inhibition of MAPK1/3 attenuated the effects of caPKA and caRap1 on the rewarding effect of cocaine, whereas activation of MAPK1/3 restored the deficit in cocaine-induced place preference in Rap1 knockout mice, suggesting that Rap1 mediates the activation of MAPK1/3 by PKA downstream of D1Rs. MAPK1/3 appears to phosphorylate several potassium and HCN channels (Table 1) , which are potentially involved in neuronal excitability. Rasgrf2 (a specific Ras GEF) has been shown to play a role in controlling the excitability of DA neurons through I A current by MAPK (Stacey et al., 2012) . Moreover, Rasgrf1 knockout mice show reduced DA-stimulated MAPK1/3 phosphorylation in striatal neurons and organotypic slices as well as deficient behavioral responses to cocaine (Fasano et al., 2009 ). Thus, our findings can be explained by a similar recruitment of MAPK1/3 and provide a novel connection between D1R, PKA, Rap1, and MAPK1/3 pathways in MSNs. Further intensive studies are required to understand how Rap1 regulates neuronal excitability via the MAPK pathway.
In the NAc, D1R-MSNs project to the ventral pallidum and ventral mesencephalon (substantia nigra and ventral tegmental area), whereas D2R-MSNs project to the ventral pallidum (Lu et al., 1998; Smith et al., 2013) . The D1R-MSN and D2R-MSN pathways control the dynamic balance in the basal ganglia-thalamocortical circuit (Deniau et al., 2007; Graybiel, 2000; Volkow and Morales, 2015) . Because D1R-MSNs are less excitable than D2R-MSNs, the activity D2R-MSNs may predominate under basal conditions (Deniau et al., 2007; Graybiel, 2000; Maeno, 1982; Richfield et al., 1989) . When DA substantially increases due to reward-related release or repetitive cocaine administration, D1R-MSNs become more excitable, resulting in enhanced responses to excitatory input. The D1R-MSN pathway also becomes more dominant than the D2R-MSN pathway. In the present study, mice expressing caPKA or caRap1 in D1R-MSNs exhibited a striking phenotype that was characterized by potentiated conditioned place preference to cocaine. Conversely, Rap1 conditional knockout mice, which lack Rap1 in D1R-MSNs, showed impaired cocaine-induced place preference, and this impairment was restored by transfection with caRap1, but not caPKA. Taken together, these results suggest that the enhanced excitability of D1R-MSNs caused by PKA-mediated Rap1 activation promotes the rewarding effects of DA by switching the predominant pathway from the D2R-MSNs to the D1R-MSNs in the NAc.
In the present study, we succeeded in identifying more than 100 candidate PKA substrates through phosphoproteins screening, and most of these substrates have not yet been reported as part of the DA-D1R signaling pathway. It was not possible to implement this method without enriching the phosphorylated proteins using 14-3-3-coated affinity beads. In fact, many housekeeping proteins, such as actin and tubulin, were obtained as candidate PKA substrates rather than Rap1 regulators if the 14-3-3-coated affinity beads were not used. 14-3-3 binds to phospho-Ser/Thr-containing motifs in target proteins via RSXpSXP (mode 1) and RXXXpSXP (mode 2), where pS represents phosphoserine (Rittinger et al., 1999; Yaffe et al., 1997) . Additionally, 14-3-3 regulates the function, localization, and stability of target proteins depending on their phosphorylation state (Morrison, 2009; Obsil and Obsilova, 2011) . Accordingly, the phosphorylated substrates detected in the present study may play functional roles in D1R signaling in MSNs. Because a 14-3-3 binding motif must be present within the substrate molecule for it to be identified, our proteomic screening failed to detect SKF81297-and forskolin-induced phosphorylation of DARPP-32 at T34, GluR1 at S845, NR1 at S897, and MAPK1/3 at Thr 202/Tyr 204 ( Figure 1A and Table 1 ). This potential limitation leaves open the possibility for other phosphorylated substrates. We hope that novel and well-known signaling pathways will be found via the application of protein-coated beads that recognize other phospho-binding domains.
In conclusion, the phosphoproteomic analysis method enabled us to comprehensively identify PKA substrates downstream of D1Rs, including Rasgrp2. Based on our observations, we propose the following mechanism for DA-dependent reward signaling in vivo ( Figure 7D ). The binding of DA to D1Rs activates PKA to phosphorylate Rasgrp2. The phosphorylation of Rasgrp2 leads to Rap1 activation, followed by recruitment of the MAPK pathway, which increases the excitability of accumbal D1R-MSNs. The enhancement of D1R-MSN excitability increases spike firing in response to excitatory glutamatergic input from the cortex and/ or thalamus. The D1R-MSN pathway is subsequently activated, which eventually results in reward-related behaviors. The increase in the excitability of D1R-MSNs through the novel DA-PKA-Rap1-MAPK intracellular signaling pathway is the initial and crucial step that promotes accumbal processing of excitatory glutamatergic input. We believe that our phosphoprotein screening is a powerful and useful tool to increase molecular-level understanding of multifarious brain functions by elucidating the function of the DA and other excitatory and/or inhibitory neurotransmitter systems, including the glutamate and GABA systems.
EXPERIMENTAL PROCEDURES Materials
The plasmids and antibodies used in the present study are listed in Tables  S3 and S4, at S116 and S117, S554, and S586 were produced against the phosphopeptides CGNRRHpS116pS117LIDIE, CRRRAQpS554VSLEG, and CPGRRSpS586RPPEI, respectively. The specificity of these antibodies was validated as described previously (Yoshimura et al., 2005) .
Animals
Detailed information regarding mouse strains and sources is provided in Tables S5 and S6. All animal experiments were approved and performed in accordance with the guidelines for the care and use of laboratory animals established by the Animal Experiments Committee of Nagoya University Graduate School of Medicine and Fukushima Medical University.
Preparation and Incubation of Striatal Slices
Striatal slices were prepared from mice as described previously (Nishi et al., 1997) . Detailed protocols are provided in the Supplemental Experimental Procedures.
Mass Spectrometry
Mass spectrometry was performed as previously described with some modifications (Nishioka et al., 2012) . Detailed protocols are provided in the Supplemental Experimental Procedures.
In Vitro Phosphorylation Assay
The phosphorylation assay was performed as described previously (Amano et al., 1996 (Amano et al., , 2010 . Detailed protocols are provided in the Supplemental Experimental Procedures.
Analysis of the Guanine Nucleotide Exchange Activity of Rasgrp2
The guanine nucleotide exchange activity of Rasgrp2 was measured as previously described with some modifications (García-Mata et al., 2006) . Detailed protocols are provided in the Supplemental Experimental Procedures.
Immunoblotting
Detailed protocols are provided in the Supplemental Experimental Procedures. The dilution of each antibody used is shown in Table S4 .
RalGDS RBD Pull-Down Assay
The RalGDS RBD pull-down assay was performed as previously described with minor modifications (McAvoy et al., 2009; Wang et al., 2012) . Detailed protocols are provided in the Supplemental Experimental Procedures.
Immunohistochemistry Immunohistochemistry was performed as described previously with minor modifications (Kawasaki et al., 1998) . The dilution used for each antibody is shown in Table S4 . Samples were observed under a fluorescence microscope (FSX 100, Olympus) or a confocal microscope (model LSM780, Carl Zeiss).
Virus Injection
Details regarding plasmid construction, AAV preparation, and virus injection are included in the Supplemental Experimental Procedures and Table S7 . All experiments were performed 3 weeks after AAV injection. The AAV injection sites are illustrated in Figure S7 . The data obtained from animals in which the tip of the glass microinjection capillary tube ended out of the NAc were excluded.
Electrophysiological Analysis
Electrophysiological recording was performed as previously described with minor modifications (Dong et al., 2006; Miura et al., 2007) . Detailed protocols are presented in the Supplemental Experimental Procedures.
Dendritic Spine Analysis
The dendritic spine analysis was performed as previously described with minor modification (Dietz et al., 2012) . Detailed protocols are presented in the Supplemental Experimental Procedures.
Behavioral Analysis
The conditioned place-preference test was performed as previously described with minor modifications (Nagai et al., 2006) . Detailed protocols are presented in the Supplemental Experimental Procedures.
Statistical Analysis
All data are expressed as the mean ± SEM. One-way or two-way analysis of variance (ANOVA) was used, followed by the Tukey test when the F ratios were significant (p < 0.05). Significant differences between two groups were determined using Student's t test. Detailed information concerning statistical analysis is shown in Table S8 . 
